• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Cybin Inc.

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Cybin Initiates At-The-Market Equity Program of up to US$100 Million
December 30, 2025
From Cybin Inc.
Via Business Wire
Tickers CBOE CYBN
News headline image
Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq
December 19, 2025
From Cybin Inc.
Via Business Wire
Tickers CBOE CYBN
News headline image
Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights
November 13, 2025
From Cybin Inc.
Via Business Wire
Tickers CBOE CYBN
News headline image
Cybin to Participate in the Jefferies Global Healthcare Conference in London
November 12, 2025
From Cybin Inc.
Via Business Wire
Tickers CBOE CYBN
News headline image
Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025
November 06, 2025
From Cybin Inc.
Via Business Wire
Tickers CBOE CYBN
News headline image
Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
November 05, 2025
From Cybin Inc.
Via Business Wire
Tickers CBOE CYBN
News headline image
Cybin to Participate at the 2025 Milken Institute Future of Health Summit
November 03, 2025
From Cybin Inc.
Via Business Wire
Tickers CBOE CYBN
News headline image
Cybin Announces Closing of $175 Million Registered Direct Offering
October 31, 2025
From Cybin Inc.
Via Business Wire
Tickers CBOE CYBN
News headline image
Cybin Announces $175 Million Registered Direct Offering
October 28, 2025
From Cybin Inc.
Via Business Wire
Tickers CBOE CYBN
News headline image
Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones
September 23, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
September 11, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder
September 08, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
September 04, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin to Participate in the Cantor Global Healthcare Conference 2025
September 03, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin Announces Senior Leadership Changes
September 02, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin Receives Australian Approval for EMBRACE, a Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
August 26, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin Announces Results of Annual Meeting of Shareholders
August 18, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin Reports Important Progress on Key Milestones and First Quarter Fiscal Year 2026 Financial Results
August 13, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin Receives European Approval for EMBRACE, a Multinational Phase 3 Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
August 07, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin to Participate in the Canaccord Genuity 45th Annual Growth Conference
August 06, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
July 17, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
REPEAT/Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
July 01, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights
June 30, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
June 30, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics
June 13, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference
June 12, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin to Participate in the 2025 Psychedelic Science Conference
June 11, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin Announces Additional U.S. Patent Supporting its CYB004 Program in Phase 2 Development for Generalized Anxiety Disorder
June 03, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin to Participate in Water Tower Research Fireside Chat on May 29, 2025
May 22, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
News headline image
Cybin Applauds FDA Commissioner Dr. Martin Makary’s Call to Accelerate and Prioritize Research on Psychedelic Therapeutics
May 20, 2025
From Cybin Inc.
Via Business Wire
Tickers CYBN
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap